Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-08-28

Clinical Trial Update: Effect of ICCAUT Strategy on Postoperative Urinary Retention After Radical Rectal Cancer Surgery (ICCAUT-2) [NA]

View source ↗

Summary

The ICCAUT-2 trial examining a strategy to prevent postoperative urinary retention after radical rectal cancer surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Urinary Retention, Rectal Cancer | NA | Status: WITHDRAWN